The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
110946164 11094616 4 F 20160725 20150506 20160728 PER US-PFIZER INC-2015147617 PFIZER 69.00 YR F Y 79.00000 KG 20160728 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
110946164 11094616 1 PS LYRICA PREGABALIN 1 Oral 150 MG, 2X/DAY U 21446 150 MG CAPSULE, HARD BID
110946164 11094616 2 SS LYRICA PREGABALIN 1 Oral 150 MG, 2X/DAY U 21446 150 MG CAPSULE, HARD BID
110946164 11094616 3 C LANTUS INSULIN GLARGINE 1 45 IU, 1X/DAY (INJECT 45 UNITS INTO THE SKIN NIGHTLY) 0 45 IU INJECTION QD
110946164 11094616 4 C JANUMET METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE 1 Oral 1 DF, 2X/DAY (50 MG SITAGLIPTIN/1000 MG METFORMIN, WITH MEALS) 0 1 DF TABLET BID
110946164 11094616 5 C MORPHINE MORPHINE 1 0
110946164 11094616 6 C LISINOPRIL. LISINOPRIL 1 0
110946164 11094616 7 C SIMVASTATIN. SIMVASTATIN 1 0
110946164 11094616 8 C NORVASC AMLODIPINE BESYLATE 1 Oral 5 MG, DAILY 0 5 MG TABLET
110946164 11094616 9 C DIOVAN VALSARTAN 1 Oral 320 MG, DAILY 0 320 MG TABLET
110946164 11094616 10 C ASPIRIN (E.C.) ASPIRIN 1 Oral 162 MG, DAILY (81 MG, TAKE 2 TABLETS) 0 162 MG TABLET
110946164 11094616 11 C ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Oral 10 MG, AS NEEDED (DAILY) 0 10 MG TABLET
110946164 11094616 12 C CINNAMON. CINNAMON 1 Oral 1000 MG, DAILY (500 MG CAPSULE) 0 1000 MG CAPSULE
110946164 11094616 13 C COENZYME Q10 UBIDECARENONE 1 Oral 30 MG, DAILY 0 30 MG CAPSULE
110946164 11094616 14 C EPIPEN JR EPINEPHRINE 1 Intramuscular 0.15 MG, AS NEEDED (0.15 MG/0.3 ML, INTO MUSCLE) 0 .15 MG INJECTION
110946164 11094616 15 C FLAXSEED FLAX SEED 1 Oral 1000 MG, DAILY 0 1000 MG CAPSULE
110946164 11094616 16 C MAGNESIUM CITRATE. MAGNESIUM CITRATE 1 Oral 1 DF, DAILY 0 1 DF CAPSULE
110946164 11094616 17 C MULTIVITAMIN AND MINERAL 2 Oral 1 DF, DAILY 0 1 DF TABLET
110946164 11094616 18 C FISH OIL OMEGA 3 2 Oral 2 G, DAILY 0 2 G CAPSULE
110946164 11094616 19 C ZOCOR SIMVASTATIN 1 Oral 20 MG, 1X/DAY (NIGHTLY) 0 20 MG TABLET QD
110946164 11094616 20 C COUMADIN WARFARIN SODIUM 1 Oral 2 MG, DAILY 0 2 MG TABLET
110946164 11094616 21 C COUMADIN WARFARIN SODIUM 1 Oral 5 MG, DAILY 0 5 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
110946164 11094616 1 Diabetic neuropathy
110946164 11094616 2 Diabetic arthropathy
110946164 11094616 3 Type 2 diabetes mellitus
110946164 11094616 4 Diabetes mellitus
110946164 11094616 7 Blood cholesterol abnormal

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
110946164 11094616 Gait disturbance
110946164 11094616 Pain in extremity

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
110946164 11094616 1 2008 0
110946164 11094616 2 20160719 0